FLT3 antibody
Quick Overview for FLT3 antibody (ABIN7114273)
Target
See all FLT3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- FLT3 antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- fms-related tyrosine kinase 3
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:2000, IP: 1:200-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))
-
Alternative Name
- FLT3
-
Background
-
Synonyms: Receptor-type tyrosine-protein kinase FLT3|FL cytokine receptor|Fetal liver kinase-2 (FLK-2)|Fms-like tyrosine kinase 3 (FLT-3)|Stem cell tyrosine kinase 1 (STK-1)|FLT3|CD135|FLK2|STK1
Background: Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine FLT3LG and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Promotes phosphorylation of SHC1 and AKT1, and activation of the downstream effector MTOR. Promotes activation of RAS signaling and phosphorylation of downstream kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation of FES, FER, PTPN6/SHP, PTPN11/SHP-2, PLCG1, and STAT5A and/or STAT5B. Activation of wild-type FLT3 causes only marginal activation of STAT5A or STAT5B. Mutations that cause constitutive kinase activity promote cell proliferation and resistance to apoptosis via the activation of multiple signaling pathways.
-
Molecular Weight
- 130-140 kDa
-
Gene ID
- 2322
-
UniProt
- P36888
-
Pathways
- RTK Signaling
Target
-